72 related articles for article (PubMed ID: 16699054)
1. Raised serum S100B protein levels in neuropsychiatric lupus.
Schenatto CB; Xavier RM; Bredemeier M; Portela LV; Tort AB; Dedavid e Silva TL; Souza DO; Brenol JC
Ann Rheum Dis; 2006 Jun; 65(6):829-31. PubMed ID: 16699054
[TBL] [Abstract][Full Text] [Related]
2. Correlation Between B-Cell Activating Factor of the Tumor Necrosis Factor Family Level in Serum and Immune Inflammation in Patients with Neuropsychiatric Systemic Lupus Erythematosus and its Clinical Value.
Pang J; Li Y; Tao R; Li J; Wang F; Xu H
Immunol Invest; 2024 May; 53(4):559-573. PubMed ID: 38329469
[TBL] [Abstract][Full Text] [Related]
3. Autoantibodies to NR2A Peptide of the Glutamate/NMDA Receptor in Patients with Seizure Disorders in Neuropsychiatric Systemic Lupus Erythematosus.
Yang Y; Yuan C; Shen SQ; Wang XE; Mei QH; Jiang WQ; Huang Q
Mediators Inflamm; 2017; 2017():5047898. PubMed ID: 28154472
[No Abstract] [Full Text] [Related]
4. Predictive factors of psychiatric syndrome in patients with systemic lupus erythematosus.
Geng W; Zhang S; Cao J; Hong X; Duan Y; Jiang Y; Wei J
Front Immunol; 2024; 15():1323209. PubMed ID: 38585267
[TBL] [Abstract][Full Text] [Related]
5. Prediction model for developing neuropsychiatric systemic lupus erythematosus in lupus patients.
Feng SY; Su LC; Liu XY; Qin Z; Fu L; Huang AF; Xu WD
Clin Rheumatol; 2024 Jun; 43(6):1881-1896. PubMed ID: 38676758
[TBL] [Abstract][Full Text] [Related]
6. Novel CSF biomarkers for diagnosis and integrated analysis of neuropsychiatric systemic lupus erythematosus: based on antibody profiling.
Ni J; Chen C; Wang S; Liu X; Tan L; Lu L; Fan Y; Hou Y; Dou H; Liang J
Arthritis Res Ther; 2023 Sep; 25(1):165. PubMed ID: 37684700
[TBL] [Abstract][Full Text] [Related]
7. Neuropsychiatric lupus in late- and early-onset systemic lupus erythematosus patients: a systematic review and meta-analysis.
Pamuk ON; Raza AA; Hasni S
Rheumatology (Oxford); 2024 Jan; 63(1):8-15. PubMed ID: 37341643
[TBL] [Abstract][Full Text] [Related]
8. A lack of association between elevated serum levels of S100B protein and autoimmunity in autistic children.
Al-Ayadhi LY; Mostafa GA
J Neuroinflammation; 2012 Mar; 9():54. PubMed ID: 22420334
[TBL] [Abstract][Full Text] [Related]
9. Performance of eye sign combined with increased interleukin-6 in cerebrospinal fluid in patients with neuropsychiatric lupus erythematosus.
Shi LH; Liu ZY; Yu SJ; Xia Q; Zhao J; Wu R
Int J Rheum Dis; 2023 Aug; 26(8):1464-1473. PubMed ID: 37366596
[TBL] [Abstract][Full Text] [Related]
10. [Analysis of clinical characteristics and risk factors in patients with neuropsychiatric systemic lupus erythematosus (NPSLE)].
Liu J; Jia S; Wang P; Lyu T; Hu Y; Zhang Y
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2023 Oct; 39(10):924-927. PubMed ID: 37882716
[TBL] [Abstract][Full Text] [Related]
11. Autoantibodies in Neuropsychiatric Systemic Lupus Erythematosus (NPSLE): Can They Be Used as Biomarkers for the Differential Diagnosis of This Disease?
Manca E
Clin Rev Allergy Immunol; 2022 Oct; 63(2):194-209. PubMed ID: 34115263
[TBL] [Abstract][Full Text] [Related]
12. Gender differences in plasma S100B levels of patients with major depressive disorder.
Wu Y; Lu Y; Kong L; Xie Y; Liu W; Yang A; Xin K; Yan X; Wu L; Liu Y; Zhu Q; Cao Y; Zhou Y; Jiang X; Tang Y; Wu F
BMC Psychiatry; 2024 May; 24(1):387. PubMed ID: 38783266
[TBL] [Abstract][Full Text] [Related]
13. Peripheral levels of brain-derived neurotrophic factor and S100B in neuropsychiatric systemic lupus erythematous.
Noris-García E; Arce S; Nardin P; Lanigan ME; Acuña V; Gutierrez F; Robinson-Agramonte MA; Gonçalves CA
Lupus; 2018 Nov; 27(13):2041-2049. PubMed ID: 30376438
[TBL] [Abstract][Full Text] [Related]
14. Neuropsychiatric Manifestations in Systemic Lupus Erythematosus Patients at a Tertiary Hospital in Peru.
Camones-Huerta J; Arias-Osorio C; Rodriguez-Hurtado D; Aguilar-Olano J
Eur J Rheumatol; 2023 Oct; 10(4):143-147. PubMed ID: 37850607
[TBL] [Abstract][Full Text] [Related]
15. Emerging Molecular Markers Towards Potential Diagnostic Panels for Lupus.
Tan G; Baby B; Zhou Y; Wu T
Front Immunol; 2021; 12():808839. PubMed ID: 35095896
[TBL] [Abstract][Full Text] [Related]
16. Neuro-psychiatric manifestations in patients with systemic lupus erythematosus: A systematic review and results from the Swiss lupus cohort study.
Meier AL; Bodmer NS; Wirth C; Bachmann LM; Ribi C; Pröbstel AK; Waeber D; Jelcic I; Steiner UC;
Lupus; 2021 Sep; 30(10):1565-1576. PubMed ID: 34152246
[TBL] [Abstract][Full Text] [Related]
17. Anti-NR2 antibodies, blood-brain barrier, and cognitive dysfunction.
Gulati G; Iffland PH; Janigro D; Zhang B; Luggen ME
Clin Rheumatol; 2016 Dec; 35(12):2989-2997. PubMed ID: 27357716
[TBL] [Abstract][Full Text] [Related]
18. Lupus brain fog: a biologic perspective on cognitive impairment, depression, and fatigue in systemic lupus erythematosus.
Mackay M
Immunol Res; 2015 Dec; 63(1-3):26-37. PubMed ID: 26481913
[TBL] [Abstract][Full Text] [Related]
19. Biomarkers for CNS involvement in pediatric lupus.
Rubinstein TB; Putterman C; Goilav B
Biomark Med; 2015; 9(6):545-58. PubMed ID: 26079959
[TBL] [Abstract][Full Text] [Related]
20. Autoantibodies involved in neuropsychiatric manifestations associated with systemic lupus erythematosus: a systematic review.
Sciascia S; Bertolaccini ML; Roccatello D; Khamashta MA; Sanna G
J Neurol; 2014 Sep; 261(9):1706-14. PubMed ID: 24952022
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
